Metadata
- Name
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04449874
- Description
- This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety,
pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or
metastatic solid tumors with a KRAS G12C mutation. - Data or Study Types
- clinical trial
- Keywords
- SHP2, GDC-1971, KRAS G12C, GDC-6036, Erlotinib, Atezolizumab, Bevacizumab, Colorectal Cancer, Non-Small Cell Lung Cancer, Metastatic Solid Tumor, Cetuximab
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2020
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04449874
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04449874